Ibuprom Rr Max

Ibuprofen, the active ingredient in Ibuprom Rr Max, is a nonsteroidal anti-inflammatory drug (NSAID) presented as an oral tablet for oral use. It provides analgesic, antipyretic and anti‑inflammatory effects for mild to moderate pain and fever in adults.

GNH USA supplies Ibuprom Rr Max as a licensed, GDP-compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Ibuprofen is used to relieve pain, reduce fever, and decrease inflammation in various musculoskeletal and systemic conditions.

- Mild to moderate pain: alleviates headache, dental, menstrual, or musculoskeletal discomfort - Fever: lowers elevated body temperature associated with infections or inflammatory states - Osteoarthritis: reduces joint pain and improves function in degenerative joint disease - Rheumatoid arthritis: helps control inflammatory joint pain and swelling

Common Side Effects: - Gastrointestinal upset: nausea, dyspepsia, or heartburn - Headache: mild to moderate intensity - Dizziness: transient sensation of light‑headedness - Rash: mild skin irritation or itching

Serious or Rare Side Effects: - Gastrointestinal bleeding or ulcer perforation - Acute renal impairment, especially in volume‑depleted patients - Severe allergic reactions such as anaphylaxis or angioedema - Stevens‑Johnson syndrome or toxic epidermal necrolysis - Hepatic injury: elevated liver enzymes or hepatitis

Before using Ibuprom Rr Max, consider the following precautions: - Assess gastrointestinal risk: evaluate history of ulcers or bleeding - Monitor renal function: especially in patients with dehydration or chronic kidney disease - Avoid in third‑trimester pregnancy: risk of fetal complications - Use the lowest effective dose: minimize potential adverse events - Store at ambient temperature: keep in the original container, protect from moisture and heat

Ibuprom Rr Max may interact with several medicines. Review the following categories:

Major Interactions (Avoid): - Anticoagulants (e.g., warfarin): increased bleeding risk - Selective serotonin reuptake inhibitors (SSRIs): heightened gastrointestinal bleeding - Lithium: increased lithium serum concentrations - Methotrexate: reduced clearance leading to toxicity

Moderate Interactions (Monitor Closely): - ACE inhibitors: possible reduction in renal function - Diuretics: risk of renal impairment when combined - Beta‑blockers: may attenuate antihypertensive effect